1. Epigenetics
  2. Histone Acetyltransferase
  3. KI-TOX-A3

KI-TOX-A3 is a TOX protein-protein interaction inhibitor that blocks the TOX-KAT7 protein-protein interaction with an IC50 of 0.51 μM. KI-TOX-A3 induces proteasomal degradation of TOX, restores KAT7-mediated H3K14 acetylation, reverses exhaustion of CD8+ T cells, and inhibits the proliferation of T cell acute lymphoblastic leukemia (T-ALL) cells. KI-TOX-A3 shows promise for use in studies of hematological malignancies such as T-ALL.

For research use only. We do not sell to patients.

KI-TOX-A3

KI-TOX-A3 Chemical Structure

CAS No. : 1351116-34-1

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All Histone Acetyltransferase Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

KI-TOX-A3 is a TOX protein-protein interaction inhibitor that blocks the TOX-KAT7 protein-protein interaction with an IC50 of 0.51 μM. KI-TOX-A3 induces proteasomal degradation of TOX, restores KAT7-mediated H3K14 acetylation, reverses exhaustion of CD8+ T cells, and inhibits the proliferation of T cell acute lymphoblastic leukemia (T-ALL) cells. KI-TOX-A3 shows promise for use in studies of hematological malignancies such as T-ALL[1].

In Vitro

KI-TOX-A3 (0.156-10 μM) potently inhibits the TOX-KAT7 protein-protein interaction in cell-free ELISA assays, with an IC50 of 0.51 μM[1].
KI-TOX-A3 (100 μM) binds directly to purified full-length TOX protein in cell-free ITC assays, with a Kd value of 1.05 μM[1].
KI-TOX-A3 (0.15-10 μM) binds directly to biotinylated full-length recombinant human TOX protein in cell-free SPR assays, with a Kd of 0.92 μM[1].
KI-TOX-A3 (20-40 μM) selectively competes for binding to TOX protein in Molt-4 cell lysates[1].
KI-TOX-A3 (0-10 μM) dose-dependently restores TOX protein-inhibited KAT7-mediated H3K14 acetylation in cell-free in vitro assays[1].
KI-TOX-A3 (5-10 μM; 24 h) inhibits the protein-protein interaction between TOX and KAT7 in Molt-4 T-ALL cells[1].
KI-TOX-A3 (96 h) exerts selective cytotoxicity against TOX-dependent T-ALL and CTCL cell lines, with IC50 values ranging from 2.0 μM to 6.3 μM after 96 h of treatment, whereas it shows much lower toxicity against TOX-independent cell lines[1].
KI-TOX-A3 (10 μM) induces S-phase cell cycle arrest in Jurkat T-ALL cells[1].
KI-TOX-A3 (5-10 μM; 4-12 h) induces proteasome-dependent degradation of TOX protein in Molt-4 T-ALL cells[1].
KI-TOX-A3 (0.625-10 μM; 2-12 h) dose-dependently reduces TOX mRNA levels in Jurkat T-ALL cells[1].
KI-TOX-A3 (2.5-10 μM; 24 h) reduces the expression of exhaustion markers TIM-3 and LAG-3, promotes the expression of effector cytokines, upregulates PD-1 expression in exhausted primary human CD8+ T cells, restores the cytotoxic activity of exhausted primary human CD8+ T cells against CD19+ Ramos cells, and restores the acetylation level of H3K14 in exhausted primary human CD8+ T cells to a level comparable to that of non-exhausted T cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: Molt-4 T-ALL cells
Concentration: 5 μM, 10 μM
Incubation Time: 0, 2, 4, 6, 8, 12 h (10 μM); 12 h (5 μM, 10 μM)
Result: Reduced TOX protein levels after 4 h of treatment at 10 μM; the proteasome inhibitor MG132 (HY-13259) (1 μM) rescued TOX protein levels in cells treated with 5 μM or 10 μM KI-TOX-A3 for 12 h, indicating proteasome-dependent degradation.

Real Time qPCR[1]

Cell Line: Jurkat T-ALL cells
Concentration: 0.625, 1.25, 2.5, 5, 10 μM
Incubation Time: 2, 4, 6, 8, 12 h
Result: Decreased TOX mRNA levels in a dose-dependent manner after 12 h of treatment; significant reductions in mRNA levels were observed after 4 h of 10 μM treatment, with further decreases over time.

Cell Cytotoxicity Assay[1]

Cell Line: Exhausted primary human CD8+ T cells, CD19+ Ramos cells
Concentration: 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Restored cytotoxic activity of exhausted CD8+ T cells against CD19+ Ramos cells, with ~50% improved killing efficiency compared to DMSO-treated exhausted T cells.
Molecular Weight

319.31

Formula

C18H13N3O3

CAS No.
Appearance

Solid

Color

Yellow to orange

SMILES

OCC1=CC=C(C2=C(CC3=C4C=CC(O)=C3)C4=NC(N)=C2C#N)O1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 4.17 mg/mL (13.06 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.1318 mL 15.6588 mL 31.3175 mL
5 mM 0.6264 mL 3.1318 mL 6.2635 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation

Purity: 99.15%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.1318 mL 15.6588 mL 31.3175 mL 78.2938 mL
5 mM 0.6264 mL 3.1318 mL 6.2635 mL 15.6588 mL
10 mM 0.3132 mL 1.5659 mL 3.1318 mL 7.8294 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
KI-TOX-A3
Cat. No.:
HY-176244
Quantity:
MCE Japan Authorized Agent: